HUTCHMED (China) (HCM) Net Income - Minority (2014 - 2021)
HUTCHMED (China) (HCM) posted quarterly Net Income - Minority of -$14000.0 for Q1 2021, up 79.41% year-over-year from -$7803.3 in Q1 2020, and up 79.41% quarter-over-quarter from -$68000.0 in Q1 2020.
HUTCHMED (China) (HCM) Net Income - Minority (2014 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Net Income - Minority for 8 consecutive years, with -$14000.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Net Income - Minority rose 79.41% year-over-year to -$14000.0; the TTM figure through Mar 2021 stood at -$14000.0 (up 79.41% YoY), while the FY2019 annual figure was -$505000.0, down 31.51% from the prior year.
- Net Income - Minority climbed to -$14000.0 in Q1 2021 per HCM's latest filing, from -$68000.0 in the prior quarter.
- Across five years, Net Income - Minority topped out at $29000.0 in Q4 2017 and bottomed at -$505000.0 in Q4 2019.
- Historically, Net Income - Minority has averaged -$188400.0 across 5 years, with a median of -$68000.0 in 2020.
- Annual changes were most pronounced in 2017 — Net Income - Minority surged 111.69% — and 2018, when it sank 1424.14%.
- HUTCHMED (China)'s Net Income - Minority stood at $29000.0 in 2017, then tumbled by 1424.14% to -$384000.0 in 2018, then slumped by 31.51% to -$505000.0 in 2019, then surged by 86.53% to -$68000.0 in 2020, then jumped by 79.41% to -$14000.0 in 2021.
- Business Quant data shows HCM's Net Income - Minority at -$14000.0 in Q1 2021, -$68000.0 in Q1 2020, and -$505000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | HUTCHMED (China) | 2.16 Bn | 2.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -14,000.00 |
| Mar 31, 2020 | -68,000.00 |
| Dec 31, 2019 | -505,000.00 |
| Dec 31, 2018 | -384,000.00 |
| Dec 31, 2017 | 29,000.00 |
| Dec 31, 2016 | -248,000.00 |
| Jun 30, 2016 | 37,000.00 |
| Dec 31, 2015 | -160,000.00 |
| Jun 30, 2015 | -67,000.00 |
| Dec 31, 2014 | -3.06 Mn |